When it comes to Phase 1 injectable trials, every detail matters – every study, every decision, every dollar. And as Singota Solutions’ recent “Get $mart: One Year Out from Phase 1 Injectable Trials, Avoid 3 Expensive Mistakes” webinar proved, there are plenty of avoidable pitfalls that can derail a promising drug product before it even gets started.
This exclusive event, held on March 6, 2025, featured expert insights from Ryan Memmer and Robert Sleiman, PhD, two industry veterans who have guided countless injectable products from early development through clinical trials. If you weren’t able to tune in, don’t worry – Singota’s Get $mart event is now available on-demand, below:
